Detailed, evidence-based regimens for providers in cancer care. Health care professionals, learn how you can participate in the Cancer Therapy Pathways Program today.
Health care professionals can help enhance quality and value in cancer care through our Cancer Therapy Pathways and Regimens. Cancer Therapy Pathways and Regimens are detailed, evidence-based regimens associated with better clinical outcomes that we’ve selected through rigorous evaluation for specific cancer types and states.
Review the full list of the Cancer Therapy Pathways and Regimens
Access our self-paced guide for everything you need to know about Cancer Therapy Pathways and Regimens
Select the Cancer Therapy Pathways and Regimens, if appropriate, and track your progress in the Optum Cancer Guidance Program tool.
Submit your prior authorization requests for chemotherapy or related therapies through the CGP tool for patients who are UnitedHealthcare Community Plan, Medicare Advantage or commercial plan members. Providers in all states are eligible to use our Cancer Therapy Pathways and Regimens.
Note: Pathway selection isn't required to receive prior authorization approval for therapy.
We use a comprehensive literature review of all National Comprehensive Cancer Network (NCCN)-recommended regimens.
We select regimens by efficacy, safety/toxicity and medication drug cost, which we only review when efficacy and safety between regimens are comparable. We also use our member data to better understand the typical duration of therapy, hospitalization rates and total cost of care.
The UnitedHealthcare Oncology Advisory Committee and disease-specific expert consultants review and evaluate each therapy pathway. We select the members of this committee for their clinical expertise and diverse perspectives. The committee includes practicing medical oncologists from academic medical centers and community oncology practices.
Email unitedoncology@uhc.com or connect with us through chat 24/7 in the UnitedHealthcare Provider Portal.